The STEP trial program examining higher-dose semaglutide (2.4 mg weekly) for weight management demonstrated mean weight loss of 12% to 15% over 68 weeks in adults with obesity, significantly exceeding placebo
The median follow-up of the trial was relatively short at 15.9 months
Full-length T4 clearly binds G-actin
GLP-1 (Glucagon-Like Peptide-1) is a natural hormone that is vital in regulating blood sugar levels
Looking ahead, Al-Aly said, the findings support the case for clinical trials to test GLP-1 medications as treatments for addiction in their own right, including trials powered to measure effects on overdose and drug-related death
According to Statista, the global beauty & personal care market is projected to generate a revenue of USD 677.19 billion in 2025, and glutathione is one of the important ingredients in the beauty and personal care market